Видео ютуба по тегу Laurus Labs Revenue

Laurus Labs Q3 FY26 Earnings Conference Call | Concall.in
Laurus Labs Q3 FY26 Earnings Conference Call | Concall.in
Laurus Labs Q2 Review: Revenue Up By 53% In CDMO Biz; Is FY27 Outlook Better Than FY26?
Laurus Labs Q2 Review: Revenue Up By 53% In CDMO Biz; Is FY27 Outlook Better Than FY26?
Laurus Labs Ltd Q3 FY2025-26 Earnings Conference Call
Laurus Labs Ltd Q3 FY2025-26 Earnings Conference Call
Laurus Labs Earnings Call for Q2FY26
Laurus Labs Earnings Call for Q2FY26
Laurus Labs Q2 FY26 Earnings Conference Call | Concall.in
Laurus Labs Q2 FY26 Earnings Conference Call | Concall.in
How The US Biosecure Act Will Impact Laurus Labs | Laurus Labs Stock Analysis | Know Your Company
How The US Biosecure Act Will Impact Laurus Labs | Laurus Labs Stock Analysis | Know Your Company
Laurus Labs Q3FY26 Earnings Call | Laurus Labs Q3FY26 Earnings ConCall | Laurus Labs Ltd
Laurus Labs Q3FY26 Earnings Call | Laurus Labs Q3FY26 Earnings ConCall | Laurus Labs Ltd
Laurus Labs Ltd Q2 FY2025-26 Earnings Conference Call
Laurus Labs Ltd Q2 FY2025-26 Earnings Conference Call
Laurus Labs Q2FY26 Earnings Conference Call | Laurus Labs Q2FY26 Earnings Concall
Laurus Labs Q2FY26 Earnings Conference Call | Laurus Labs Q2FY26 Earnings Concall
Jefferies, Goldman Sachs Bearish On Laurus Labs Post Q2FY26 Earnings While DAM Capital Is Bullish
Jefferies, Goldman Sachs Bearish On Laurus Labs Post Q2FY26 Earnings While DAM Capital Is Bullish
Laurus Labs Earnings Call for Q1FY26
Laurus Labs Earnings Call for Q1FY26
'No Plans To List CDMO Biz' Says Laurus Labs Founder As Vertical Aids Revenue Growth Of 31.4% YoY
'No Plans To List CDMO Biz' Says Laurus Labs Founder As Vertical Aids Revenue Growth Of 31.4% YoY
Laurus Labs Q2 Review: Revenue Up By 53% In FY27 Outlook Better Than FY26? 😃
Laurus Labs Q2 Review: Revenue Up By 53% In FY27 Outlook Better Than FY26? 😃
Laurus Labs Reported Strong Margin Expansion, With Q3 EBITDA Margin At 27% | Dr. Satyanarayana Chava
Laurus Labs Reported Strong Margin Expansion, With Q3 EBITDA Margin At 27% | Dr. Satyanarayana Chava
Laurus Labs Q1 FY26 Results Explained | Revenue, Profit, Margin & Outlook Breakdown
Laurus Labs Q1 FY26 Results Explained | Revenue, Profit, Margin & Outlook Breakdown
Laurus Labs Q3 FY26 Concall: Management on CDMO Momentum and API Recovery
Laurus Labs Q3 FY26 Concall: Management on CDMO Momentum and API Recovery
#Q1WithBQ: Analysing Laurus Labs' Earnings
#Q1WithBQ: Analysing Laurus Labs' Earnings
Laurus Labs: Strong CDMO Execution Drives 33% Revenue Growth and Future $600 Million
Laurus Labs: Strong CDMO Execution Drives 33% Revenue Growth and Future $600 Million
Our CDMO Business Revenue Is Moving Towards ₹500 Crore Per Quarter: Laurus Labs | CNBC TV18
Our CDMO Business Revenue Is Moving Towards ₹500 Crore Per Quarter: Laurus Labs | CNBC TV18
Laurus Labs Q3 FY26 Profit Surged 174% – How?
Laurus Labs Q3 FY26 Profit Surged 174% – How?